GLP-2 is a synthetic dual incretin receptor agonist peptide developed exclusively for laboratory and scientific research applications. It is widely studied in experimental models for its interactions with metabolic signaling pathways, receptor-mediated regulatory systems, and peptide–receptor dynamics within controlled research environments.